Article

Breakthrough Covid-19 cases despite tixagevimab and cilgavimab (Evusheld™) prophylaxis in kidney transplant recipients

2022-03-19

Abstract excerpt

While the combination of casirivimab-imdevimab (Ronapreve™ Roche Regeneron) has been shown to confer satisfactory protection against the delta variant kidney transplant recipients (KTRs) with COVID-19, it has limited neutralizing activity against the current variants of concern (Omicron BA.1, BA.1.1 and BA.2). In contrast, cilgavimab-tixagevimab combination (Evusheld™, Astra Zeneca) retains a partial neutralizing...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 068fd5ba-eef8-5220-b66a-8fa2b41b3f93
DOI: 10.1101/2022.03.19.22272575

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Breakthrough Covid-19 cases despite tixagevimab and cilgavimab (Evusheld™) prophylaxis in kidney transplant recipientsDOI 10.1101/2022.03.19.22272575Read

Pre-exposure prophylaxis for COVID-19 with Tix-agevimab/Cilgavimab in kidney transplant recipients in the Kraken variant (XBB.1.5) era: A Single-center ExperienceSemantic proximity Read

Pre-exposure prophylaxis with Evusheld™ elicits limited neutralizing activity against the omicron variant in kidney transplant patientsSemantic proximity Read

Kidney Transplant Recipients and Omicron: Outcomes, effect of vaccines and the efficacy and safety of novel treatmentsSemantic proximity Read

Humoral and cellular immune correlates of protection against COVID-19 in kidney transplant recipientsSemantic proximity Read

COVID-19 Outcomes in Kidney Transplant Recipients in a German Transplant CenterSemantic proximity Read

Unveiling Protection: A Meta-Analysis of Tixagevimab-Cilgavimab Prophylaxis in 28,950 Transplant Recipients and Immunocompromised Patients Against COVID-19Semantic proximity Read

A Third COVID-19 Vaccine Dose in Kidney Transplant Recipients Induces Antibody Response to Vaccine and Omicron Variants but Shows Limited Ig Subclass SwitchingSemantic proximity Read

Real World Effectiveness of Tixagevimab/cilgavimab (Evusheld) in the Omicron EraSemantic proximity Read

Clinical Outcomes of Post Renal Transplant Patients with COVID-19 Infection: A single-center case seriesSemantic proximity Read

Comparative Study of COVID-19 Infection in Renal Transplant Recipients and Non Transplant RecipientsSemantic proximity Read

What is New in Prophylaxis and Treatment of Covid- 19 in Renal Transplant Patients?Semantic proximity Read

Evaluation of neutralizing capacity of tixagevimab plus cilgavimab: a case-series study with comparison to a vaccinated populationSemantic proximity Read